Gilead to donate remdesivir for emergency use against Marburg disease in Rwanda

(Reuters) – Gilead Sciences said on Thursday it would donate about 5,000 vials of its antiviral remdesivir to the Rwanda Medical Supply for emergency use in response to the Marburg virus disease outbreak.

(Reporting by Mariam Sunny in Bengaluru’ Editing by Anil D’Silva)